16 insiders have filed at NHC since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| National Health Corp | Insider | 1.03M | 6.537% | 2 sells $6.0M | |
| Adams W Andrew | Director | 704.9k | 4.47% | 1 buys $125k | |
| Adams Robert G | Director | 443.9k | 2.815% | 1 buys $131k | |
| Laroche Richard F JR | Director | 205.8k | 1.305% | 1 buys $129k | |
| Ussery Robert Michael | President & COO | 158.5k | 1.005% | ||
| Burgess Ernest G III | Director | 86.2k | 0.546% | ||
| Hassan Emil E | Director | 65.6k | 0.416% | 4 sells $3.1M | |
| Flatt Stephen Fowler | CEO | 65.5k | 0.415% | 2 sells $625k | |
| Abernathy James Paul | Director | 43.3k | 0.275% | 2 sells $310k | |
| Kidd Brian F | SVP, CFO | 29.1k | 0.185% | 1 sells $260k | |
| Flatt Ben Anderson SR | Senior VP & CIO | 19.6k | 0.124% | ||
| Dodson Vicki L | SR.VP Patient Srvcs | 14.4k | 0.091% | ||
| Mccreary Josh A | Senior VP & General Counsel | 12.7k | 0.081% | ||
| Mcintosh Leroy E. JR. | SVP, Anc Srvcs & Srvc Strategy | 9.3k | 0.059% | ||
| Trail Sandra Y. | Director | 7.5k | 0.048% | ||
| Shelly Timothy J. | SR.VP Operations | 3.1k | 0.02% | 2 sells $417k |
Full register at boothcheck.com/insiders/NHC. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.